Sentinel symptoms in patients with unexplained cardiac arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 1, 2012, Pages 60-66

  Krahn, Andrew D ^a   Healey, Jeffrey S ^b   Simpson, Christopher S ^c   Chauhan, Vijay S ^d   Birnie, David H ^e   Champagne, Jean ^f   Gardner, Martin ^g   Sanatani, Shubhayan ^h   Chakrabarti, Santabhanu ^h   Yee, Raymond ^a   Skanes, Allan C ^a   Leong Sit, Peter ^a   Ahmad, Kamran ⁱ   Gollob, Michael H ^e   Klein, George J ^a   Gula, Lorne J ^a   Sheldon, Robert S ^j  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^h BC CHILDREN S HOSPITAL   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

cardiac arrest; diagnosis; genetics; symptoms; syncope

Indexed keywords

ADULT; ARTICLE; CALGARY SYNCOPE SCORE; FAMILY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYNCOPE;

ADULT; CANADA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENTINEL SURVEILLANCE; STROKE VOLUME; SYNCOPE;

EID: 84856006996     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02185.x     Document Type: Article

References (47)

1. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L,: Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008; 117: 2184-2191.
2. Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L,: Long-QT syndrome after age 40. Circulation 2008; 117: 2192-2201.
3. Kaufman ES, McNitt S, Moss AJ, Zareba W, Robinson JL, Hall WJ, Ackerman MJ, Benhorin J, Locati ET, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L,: Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm 2008; 5: 831-836.
4. Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL, Qi M, Goldenberg I, Hobbs JB, Ackerman MJ, Benhorin J, Hall WJ, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L,: Long QT syndrome in adults. J Am Coll Cardiol 2007; 49: 329-337. (Pubitemid 46097383)
5. Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, Qi M, Robinson JL, Sauer AJ, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Towbin JA, Vincent GM, Zhang L,: Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006; 296: 1249-1254. (Pubitemid 44394896)
6. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J,: Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004; 292: 1341-1344. (Pubitemid 39223225)
7. Marcus FI, Zareba W, Calkins H, Towbin JA, Basso C, Bluemke DA, Estes NA, III, Picard MH, Sanborn D, Thiene G, Wichter T, Cannom D, Wilber DJ, Scheinman M, Duff H, Daubert J, Talajic M, Krahn A, Sweeney M, Garan H, Sakaguchi S, Lerman BB, Kerr C, Kron J, Steinberg JS, Sherrill D, Gear K, Brown M, Severski P, Polonsky S, McNitt S,: Arrhythmogenic right ventricular cardiomyopathy/ dysplasia clinical presentation and diagnostic evaluation: Results from the North American multidisciplinary study. Heart Rhythm 2009; 6: 984-992.
8. Tester DJ, Kopplin LJ, Creighton W, Burke AP, Ackerman MJ,: Pathogenesis of unexplained drowning: New insights from a molecular autopsy. Mayo Clin Proc 2005; 80: 596-600. (Pubitemid 40628814)
9. Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA,: Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005; 42: 863-870. (Pubitemid 41598196)
10. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ,: Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: A molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc 2004; 79: 1380-1384. (Pubitemid 39453301)
11. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I,: Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89: 66-70. (Pubitemid 36044293)
12. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A,: Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69-74. (Pubitemid 34747444)
13. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ,: Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998; 339: 960-965. (Pubitemid 28455098)
14. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino VV, Danieli GA,: Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200. (Pubitemid 32095402)
15. Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J,: Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002; 105: 1342-1347. (Pubitemid 34260426)
16. Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, Davies MJ, McKenna W,: Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 2003; 362: 1457-1459. (Pubitemid 37352884)
17. Krahn AD, Gollob M, Yee R, Gula LJ, Skanes AC, Walker BD, Klein GJ,: Diagnosis of unexplained cardiac arrest: Role of adrenaline and procainamide infusion. Circulation 2005; 112: 2228-2234. (Pubitemid 41464564)
18. Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB,: Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77: 413-421. (Pubitemid 34465148)
19. Vyas H, Hejlik J, Ackerman MJ,: Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: Diagnostic accuracy of the paradoxical QT response. Circulation 2006; 113: 1385-1392. (Pubitemid 43739434)
20. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL,: Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006; 17: 857-864. (Pubitemid 44079745)
21. Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J, Gardner M, Sanatani S, Exner DV, Klein GJ, Yee R, Skanes AC, Gula LJ, Gollob MH,: Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 2009; 120: 278-285.
22. Schwartz PJ, Moss AM, Vincent GM, Crampton RS,: Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88: 782-784. (Pubitemid 23228078)
23. Swan H, Saarinen K, Kontula K, Toivonen L, Viitasalo M,: Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. J Am Coll Cardiol 1998; 32: 486-491. (Pubitemid 28396501)
24. Ainsworth CD, Skanes AC, Klein GJ, Gula LJ, Yee R, Krahn AD,: Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. Heart Rhythm 2006; 3: 416-423.
25. Bhandari AK, Shapiro WA, Morady F, Shen EN, Mason J, Scheinman MM,: Electrophysiologic testing in patients with the long QT syndrome. Circulation 1985; 71: 63-71. (Pubitemid 15164763)
26. Li HG, Thakur RK, Yee R, Klein GJ,: The value of electrophysiologic testing in patients resuscitated from documented ventricular fibrillation. J Cardiovasc Electrophysiol 1994; 5: 805-809. (Pubitemid 24363159)
27. Gehi AK, Duong TD, Metz LD, Gomes JA, Mehta D,: Risk stratification of individuals with the Brugada electrocardiogram: A meta-analysis. J Cardiovasc Electrophysiol 2006; 17: 577-583.
28. Brugada P, Brugada R, Brugada J,: Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005; 112: 279-292; discussion 279-292.
29. Avella A, d'Amati G, Pappalardo A, Re F, Francesca Silenzi P, Laurenzi F, P DEG, Pelargonio G, Dello Russo A, Baratta P, Messina G, Zecchi P, Zachara E, Tondo C,: Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Electrophysiol 2008; 19: 1127-1134.
30. Roux JF, Dubuc M, Pressacco J, Roy D, Thibault B, Talajic M, Guerra PG, Macle L, Khairy P,: Concordance between an electroanatomic mapping system and cardiac MRI in arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol 2006; 29: 109-112.
31. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F,: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71: 215-218.
32. Haissaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, Pasquie JL, Nogami A, Babuty D, Yli-Mayry S, De Chillou C, Scanu P, Mabo P, Matsuo S, Probst V, Le Scouarnec S, Defaye P, Schlaepfer J, Rostock T, Lacroix D, Lamaison D, Lavergne T, Aizawa Y, Englund A, Anselme F, O'Neill M, Hocini M, Lim KT, Knecht S, Veenhuyzen GD, Bordachar P, Chauvin M, Jais P, Coureau G, Chene G, Klein GJ, Clementy J,: Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008; 358: 2016-2023. (Pubitemid 351681636)
33. Klatsky AL, Oehm R, Cooper RA, Udaltsova N, Armstrong MA,: The early repolarization normal variant electrocardiogram: Correlates and consequences. Am J Med 2003; 115: 171-177. (Pubitemid 37338140)
34. Gussak I, Antzelevitch C,: Early repolarization syndrome: Clinical characteristics and possible cellular and ionic mechanisms. J Electrocardiol 2000; 33: 299-309.
35. Rosso R, Kogan E, Belhassen B, Rozovski U, Scheinman MM, Zeltser D, Halkin A, Steinvil A, Heller K, Glikson M, Katz A, Viskin S,: J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: Incidence and clinical significance. J Am Coll Cardiol 2008; 52: 1231-1238.
36. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M,: Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 2006; 27: 344-350. (Pubitemid 43100031)
37. Sheldon R, Rose S, Ritchie D, Connolly SJ, Koshman ML, Lee MA, Frenneaux M, Fisher M, Murphy W,: Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol 2002 Jul 3; 40: 142-148. (Pubitemid 34701389)
38. Sud S, Klein GJ, Skanes AC, Gula LJ, Yee R, Krahn AD,: Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring. Heart Rhythm 2009; 6: 238-243.
39. Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L, Alvarez M, Errazquin F, Beiras J, Bottoni N, Donateo P,: Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 2001; 104: 2045-2050. (Pubitemid 33028910)
40. Kanjwal K, Kanjwal Y, Karabin B, Grubb BP,: Clinical symptoms associated with asystolic or bradycardic responses on implantable loop recorder monitoring in patients with recurrent syncope. Int J Med Sci 2009; 6: 106-110.
41. Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S,: Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009; 54: 2052-2062.
42. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R,: Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103: 89-95. (Pubitemid 32050441)
43. Goldenberg I, Moss AJ, Zareba W,: Sudden cardiac death without structural heart disease: Update on the long QT and Brugada syndromes. Curr Cardiol Rep 2005; 7: 349-356. (Pubitemid 41419350)
44. Jons C, Moss AJ, Goldenberg I, Liu J, McNitt S, Zareba W, Qi M, Robinson JL,: Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol 2010; 55: 783-788.
45. Calkins H, Marcus F,: Arrhythmogenic right ventricular cardiomyopathy/dysplasia: An update. Curr Cardiol Rep 2008; 10: 367-375.
46. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA III, Buja G, Thiene G,: Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003; 108: 3084-3091. (Pubitemid 38031796)
47. Hofman N, Tan HL, Alders M, van Langen IM, Wilde AA,: Active cascade screening in primary inherited arrhythmia syndromes: Does it lead to prophylactic treatment? J Am Coll Cardiol 2010; 55: 2570-2576.